German watchdog calls for direct comparison of cancer immunotherapies

FRANKFURT (Reuters) - Germany's drug assessment body has criticized a lack of data directly comparing drugs in a promising new class of cancer immunotherapy, saying physicians could be overwhelmed or misled by the available information.